Soluble immune checkpoint-related proteins as predictors of tumor recurrence, survival, and T cell phenotypes in clear cell renal cell carcinoma patients
Abstract Background Immune checkpoint inhibitors have achieved unprecedented success in cancer immunotherapy. With the exception of a few candidate biomarkers, the prognostic role of soluble immune checkpoint-related proteins in clear cell renal cell cancer (ccRCC) patients is largely uninvestigated...
Main Authors: | Qinchuan Wang, Jinhua Zhang, Huakang Tu, Dong Liang, David. W. Chang, Yuanqing Ye, Xifeng Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2019-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40425-019-0810-y |
Similar Items
-
Primary clear cell adenocarcinoma of the bladder with recurrence: a case report and literature review
by: Lu Ji, et al.
Published: (2012-02-01) -
A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma
by: Su Gao, et al.
Published: (2021-07-01) -
Predictors of response to immune checkpoint inhibition in a real world gynecologic cancer population
by: Michelle L. Kuznicki, et al.
Published: (2020-11-01) -
Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC)
by: Audrey Simonaggio, et al.
Published: (2021-01-01) -
Recurrence Patterns and Survival Outcomes in Chinese Patients with Surgically Treated Recurrent Ovarian Clear Cell Carcinoma: A Single Institutional Analysis of 45 Cases
by: Ye S, et al.
Published: (2020-02-01)